LakeShore Biopharma Co., Ltd

The momentum for this stock is not very good. LakeShore Biopharma Co., Ltd is not very popular among insiders. Tradey thinks it is not wise to invest in LakeShore Biopharma Co., Ltd.
Log in to see more information.

News

Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024
Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024

PR Newswire Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024 Lakeshore Biopharma to Hold an Extraordinary General Meeting of Shareholders on September 27, 2024...\n more…

LakeShore Biopharma appoints Wang as CEO
LakeShore Biopharma appoints Wang as CEO

Seeking Alpha - Healthcare LakeShore Biopharma appoints Wang as CEO...\n more…

LakeShore Biopharma Announces Leadership Transitions
LakeShore Biopharma Announces Leadership Transitions

PR Newswire LakeShore Biopharma Announces Leadership Transitions LakeShore Biopharma Announces Leadership Transitions PR Newswire GAITHERSBURG, Md., Sept. 4, 2024 GAITHERSBURG, Md., Sept. 4, 2024 /PRNewswire...\n more…

Catalent (CTLT) Tops Q4 Earnings and Revenue Estimates
Catalent (CTLT) Tops Q4 Earnings and Revenue Estimates

Zacks Investment Research Catalent (CTLT) came out with quarterly earnings of $0.65 per share, beating the Zacks Consensus Estimate of $0.46 per share. This compares to earnings of $0.09 per share a year ago. These figures...\n more…

Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates
Sol-Gel Technologies Ltd. (SLGL) Surpasses Q2 Earnings and Revenue Estimates

Zacks Investment Research Sol-Gel Technologies Ltd. (SLGL) came out with quarterly earnings of $0.07 per share, beating the Zacks Consensus Estimate of a loss of $0.20 per share. This compares to loss of $0.22 per share a...\n more…

LakeShore Biopharma Announces Financial Results for Fiscal Year 2024
LakeShore Biopharma Announces Financial Results for Fiscal Year 2024

PR Newswire LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 LakeShore Biopharma Announces Financial Results for Fiscal Year 2024 PR Newswire GAITHERSBURG, Md., Aug. 15, 2024 Gross margin...\n more…